ADIPOQ and chronic kidney disease: In patients with CKD stage II–IV, higher adiponectin levels were associated with increased serum OC levels, showing a possible OC regulation on pancreatic β-cell proliferation and adipocyte gene expression, causing an increase of insulin secretion and consequently adiponectin synthesis [49].